Nippon India Pharma Fund Direct IDCW
Summary Info
Fund Name
: Nippon India Mutual Fund
Scheme Name
: Nippon India Pharma Fund Direct IDCW
AMC
: Nippon India Mutual Fund
Type
: Open
Category
: Equity - Pharma
Launch Date
: 01-Jan-2013
Fund Manager
: Sailesh Raj Bhan
Net Assets (Rs. cr)
: 8352.16
Nippon India Pharma Fund Direct IDCW - Nav Details
Nav Date
: 27-Jun-2025
NAV [Rs.]
: 170.2477
Buy/Resale Price [Rs.]
: 0
Sell/Repurchase Price [Rs.]
: 0
Entry Load %
:
Exit Load %
:
Nippon India Pharma Fund Direct IDCW- NAV Chart
Nippon India Pharma Fund Direct IDCW- Performance(%)
Returns above 1 yr. are annualized
1W | 1M | 3M | 6M | 1Y | 3Y | 5Y | Since INC | |
|---|---|---|---|---|---|---|---|---|
| Scheme Returns | 2.05 | 1.68 | 6.14 | -0.16 | 16.65 | 26.26 | 22.9 | 18.86 |
| Category Avg | 1.89 | 1.69 | 4.95 | -2.1 | 17.82 | 25.81 | 22.2 | 17.79 |
| Category Best | 2.96 | 2.66 | 12.9 | 1.96 | 29.11 | 30.63 | 25.34 | 35.69 |
| Category Worst | 0.34 | 0.73 | 0.8 | -6.37 | 5.63 | 20.99 | 16.92 | -4.55 |
Nippon India Pharma Fund Direct IDCW- Latest Dividends
Record DateDividend %Bonus
21-Feb-20241000
Nippon India Pharma Fund Direct IDCW- Investment Details
Min. Investment(Rs.)
: 5000
Increm.Investment(Rs.)
: 1000
In & Out
In
InName Of The CompanyNo Of Shares
--
Out
InName Of The CompanyNo Of Shares
Krishna Institu.4,61,785
Fund Holdings
Asset Type | Instrument Name | Industry | Net Assets(%) | No of Shares | Mkt Value(Cr.) |
|---|---|---|---|---|---|
| Equity & Equity related Investments | |||||
| Equity | Sun Pharma.Inds. | Pharmaceuticals & Biotechnology | 12.57 | 6256349 | 1,049.56 |
| Equity | Divi's Lab. | Pharmaceuticals & Biotechnology | 9.49 | 1198808 | 792.65 |
| Equity | Lupin | Pharmaceuticals & Biotechnology | 5.82 | 2483991 | 486.29 |
| Equity | Cipla | Pharmaceuticals & Biotechnology | 5.62 | 3200000 | 469.02 |
| Equity | Dr Reddy's Labs | Pharmaceuticals & Biotechnology | 5.49 | 3662170 | 458.21 |
| Equity | Apollo Hospitals | Healthcare Services | 5.34 | 648795 | 446.40 |
| Equity | Medplus Health | Retailing | 4.20 | 3627277 | 350.54 |
| Equity | Glaxosmi. Pharma | Pharmaceuticals & Biotechnology | 3.73 | 943731 | 311.29 |
| Equity | Vijaya Diagnost. | Healthcare Services | 3.24 | 2831564 | 270.78 |
| Equity | Narayana Hrudaya | Healthcare Services | 2.94 | 1406946 | 245.35 |
| Equity | Gland Pharma | Pharmaceuticals & Biotechnology | 2.91 | 1529352 | 242.95 |
| Equity | Ajanta Pharma | Pharmaceuticals & Biotechnology | 2.88 | 959323 | 240.86 |
| Equity | Abbott India | Pharmaceuticals & Biotechnology | 2.87 | 78677 | 239.61 |
| Equity | Dr Lal Pathlabs | Healthcare Services | 2.37 | 709112 | 197.60 |
| Equity | Aurobindo Pharma | Pharmaceuticals & Biotechnology | 2.34 | 1702630 | 195.42 |
| Equity | Mankind Pharma | Pharmaceuticals & Biotechnology | 2.24 | 757496 | 186.92 |
| Equity | Zydus Lifesci. | Pharmaceuticals & Biotechnology | 2.23 | 2000632 | 186.05 |
| Equity | Thyrocare Tech. | Healthcare Services | 2.22 | 1765838 | 185.27 |
| Equity | Pfizer | Pharmaceuticals & Biotechnology | 2.14 | 318249 | 178.64 |
| Equity | J B Chemicals & | Pharmaceuticals & Biotechnology | 2.01 | 999649 | 167.57 |
| Equity | Alkem Lab | Pharmaceuticals & Biotechnology | 1.98 | 323678 | 165.02 |
| Equity | Sanofi India | Pharmaceuticals & Biotechnology | 1.71 | 230272 | 142.59 |
| Equity | Sai Life | Pharmaceuticals & Biotechnology | 1.40 | 1545179 | 116.96 |
| Equity | Sanofi Consumer | Pharmaceuticals & Biotechnology | 1.35 | 213659 | 112.56 |
| Equity | Ipca Labs. | Pharmaceuticals & Biotechnology | 1.34 | 785412 | 111.90 |
| Equity | Suraksha Diagno. | Healthcare Services | 1.22 | 3169618 | 101.77 |
| Equity | Torrent Pharma. | Pharmaceuticals & Biotechnology | 1.15 | 303364 | 96.30 |
| Equity | Fortis Health. | Healthcare Services | 0.93 | 1103889 | 77.96 |
| Equity | Biocon | Pharmaceuticals & Biotechnology | 0.92 | 2284222 | 76.71 |
| Equity | Syngene Intl. | Healthcare Services | 0.87 | 1124795 | 72.72 |
| Equity | Emcure Pharma | Pharmaceuticals & Biotechnology | 0.75 | 470272 | 62.54 |
| Equity | Astrazeneca Phar | Pharmaceuticals & Biotechnology | 0.61 | 64078 | 51.08 |
| Equity | Akums Drugs | Pharmaceuticals & Biotechnology | 0.57 | 833718 | 47.63 |
| Equity | Indoco Remedies | Pharmaceuticals & Biotechnology | 0.55 | 1834924 | 45.99 |
| Equity | Orchid Pharma | Pharmaceuticals & Biotechnology | 0.37 | 492727 | 30.98 |
| Equity | Concord Biotech | Pharmaceuticals & Biotechnology | 0.23 | 111738 | 19.53 |
| Cash & Cash Equivalent | |||||
| Reverse Repo | TREPS | -/- | 1.52 | 0 | 127.29 |
| Cash & Cash Equivalent | C C I | -/- | 0.00 | 0 | 0.06 |
| Net CA & Others | Net CA & Others | -/- | -0.12 | 0 | -8.58 |
MY WEALTH AT RETIREMENT
Calculate the worth of your wealth at retirement
Key information
Fund House:
Nippon India Mutual Fund
Incorporation Date:
24-Feb-1995
Total Assets Managed (Cr.):
5,61,387.15
Trustee/s:
Mr. A N Shanbhag - Associ, Nippon Life India Trustee
Chairman:
NA
CEO / MD:
Mr. Sundeep Sikka
CIO:
NA
President:
NA
Director/s:
Mr. Akira Shibata, Mr. Sushil C. Tripathi, Mr. Kazuhide Toda, Mr. Takayuki Murai
Compliance Officer/s:
Mr. Muneesh Sud
Investor Service Officer/s:
Mr. Milind Nesarikar
Fund Manager/s:
Sailesh Raj Bhan
Auditors:
Haribhakti & Co LLP Chart
OTHER INFORMATION
Registered Office:
4th Floor, Tower A, Peninsula Busines -s Park, Ganapatrao Kadam Marg Lower Parel (W), Mumbai - 400013.
Contact Nos:
022-68087000/1860260111
Fax:
022-68087097
Website:
